ArticleVascular health and risk management2016

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

James E Foley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.